The Tauopathy Associated with Mutation +3 in Intron 10 of Tau: Characterization of the MSTD Family
Overview
Authors
Affiliations
Multiple system tauopathy with presenile dementia (MSTD) is an inherited disease caused by a (g) to (a) transition at position +3 in intron 10 of Tau. It belongs to the spectrum of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in Tau (FTDP-17T). Here we present the longitudinal clinical, neuropsychological, neuroimaging, neuropathological, biochemical and genetic characterization of the MSTD family. Presenting signs were consistent with the behavioural variant of frontotemporal dementia in 17 of 21 patients. Two individuals presented with an atypical form of progressive supranuclear palsy and two others with either severe postural imbalance or an isolated short-term memory deficit. Memory impairment was present at the onset in 15 patients, with word finding difficulties and stereotyped speech also being common. Parkinsonism was first noted 3 years after the onset of symptoms. Neuroimaging showed the most extensive grey matter loss in the hippocampus, parahippocampal gyrus and frontal operculum/insular cortex of the right hemisphere and, to a lesser extent, in the anterior cingulate gyrus, head of the caudate nucleus and the posterolateral orbitofrontal cortex and insular cortex bilaterally. Neuropathologically, progressive nerve cell loss, gliosis and coexistent neuronal and/or glial deposits consisting mostly of 4-repeat tau were present in frontal, cingulate, temporal and insular cortices, white matter, hippocampus, parahippocampus, basal ganglia, selected brainstem nuclei and spinal cord. Tau haplotyping indicated that specific haplotypes of the wild-type allele may act as modifiers of disease presentation. Quantitative neuroimaging has been used to analyse the progression of atrophy in affected individuals and for predicting disease onset in an asymptomatic mutation carrier. This multidisciplinary study provides a comprehensive description of the natural history of disease in one of the largest known families with FTDP-17T.
Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W.
Qi C, Lovestam S, Murzin A, Peak-Chew S, Franco C, Bogdani M Nat Struct Mol Biol. 2025; .
PMID: 40044789 DOI: 10.1038/s41594-025-01498-5.
TMEM106B amyloid filaments in the Biondi bodies of ependymal cells.
Ghetti B, Schweighauser M, Jacobsen M, Gray D, Bacioglu M, Murzin A Acta Neuropathol. 2024; 148(1):60.
PMID: 39503754 PMC: 11541264. DOI: 10.1007/s00401-024-02807-w.
Ryan B, OMara Baker A, Ilse C, Brickell K, Kersten H, Williams J J R Soc N Z. 2024; 53(4):511-531.
PMID: 39439966 PMC: 11459842. DOI: 10.1080/03036758.2022.2101483.
Tau filaments with the Alzheimer fold in cases with mutations V337M and R406W.
Qi C, Lovestam S, Murzin A, Peak-Chew S, Franco C, Bogdani M bioRxiv. 2024; .
PMID: 38746388 PMC: 11092478. DOI: 10.1101/2024.04.29.591661.
A novel variant (E342K) as a cause of familial progressive supranuclear palsy.
Li H, Li Q, Weng Q, Cui R, Yen T, Li Y Front Neurol. 2024; 15:1372507.
PMID: 38708005 PMC: 11067502. DOI: 10.3389/fneur.2024.1372507.